ATC code None PubChem CID 3074827 ECHA InfoCard 100.162.081 | CAS Number 163000-63-3 ChemSpider 2333649 Molar mass 256.3413 g/mol | |
 | ||
Synonyms Nebostinel; N-(4,4-Dimethylcyclohexyl)-L-α-glutamine | ||
Neboglamine (INN) (developmental code names CR-2249, XY-2401), formerly known as nebostinel, is a positive allosteric modulator of the glycine site of the NMDA receptor which is under investigation for Rottapharm for the treatment of schizophrenia and cocaine dependence. It shows cognition- and memory-enhancing effects in animal models. As of June 2015, it is in phase II clinical trials for both schizophrenia and cocaine abuse.
References
Neboglamine Wikipedia(Text) CC BY-SA